A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy and Safety of a Novel Formulation Comprised of Botanically Derived Inhibitors of 5AR in the Treatment of Androgenetic Alopecia Abstract Androgenetic alopecia (AGA) is characterized by a receding hairline and/or hair loss within a given pattern on the scalp. The endocrinolgic processes associated with this disorder share a remarkable degree of similarity with those implicated in the etiology of benign prostatic hyperplasia (BPH). AGA has also been shown to be responsive to drugs and agents used to treat BPH. Interestingly, certain botanical compounds have previously demonstrated efficacy against BPH. Here we report the first example of a placebo-controlled, double-blind study undertaken in order to examine the benefit of these botanical substances in the treatment of AGA. The results of this pilot study showed a highly positive response to treatment. The blinded Investigative Staff Assessment reported that 60% (6/10) study subjects dosed with the active study formulation were rated as improved at the final visit. This proof of concept study demonstrated the safety and efficacy of these botanical substances against AGA, and justifies the expansion to larger trials. For More Information on this formulation go to http://www.nsip.ws/hairgenesis/index.html @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ This mailing is done by an independent marketing co. We apologize if this message has reached you in error. Save the Planet, Save the Trees! Advertise via Email. No wasted paper! Delete with one simple keystroke! Less refuse in our Dumps! This is the new way of the new millennium To be removed please email [EMAIL PROTECTED] with the word "remove" in the subject line. @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ ---- This list is cross-posted to two mail lists. To unsubscribe, follow the instructions below for the list you subscribed to. For objectweb.org: send email to [EMAIL PROTECTED] and include in the body of the message "unsubscribe ejb-container-group". For enhydra.org: send email to [EMAIL PROTECTED] and include in the body of the message "unsubscribe ejb-container-group".
